Showing results (341-350 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|July 23, 2023
Association between maternal haemoglobin concentrations and maternal and neonatal outcomes: the prospective, observational, multinational, INTERBIO-21st fetal studyEric O Ohuma, Nusrat Jabin, Melissa F Young, et al.
The Lancet. Haematology|July 31, 2023
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trialSigismond Lasocki, Xavier Capdevila, Bruno Vielle, et al.
The Lancet. Haematology|August 31, 2023
Revisiting six established practices in the treatment of chronic myeloid leukaemiaHagop M Kantarjian, Mary Alma Welch, Elias Jabbour
The Lancet. Haematology|October 4, 2023
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised studyMeletios Athanasios Dimopoulos, Vania T M Hungria, Atanas Radinoff, et al.
The Lancet. Haematology|June 18, 2023
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021
The Lancet. Haematology|May 28, 2023
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 studyPierre Peterlin, Yannick Le Bris, Pascal Turlure, et al.
The Lancet. Haematology|May 2, 2026
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trialM Lia Palomba, Manish R Patel, Toby A Eyre, et al.
The Lancet. Haematology|May 2, 2026
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trialFranck E Nicolini, Gabriel Etienne, Françoise Huguet, et al.
The Lancet. Haematology|May 2, 2026
Guidelines for the management of acute porphyria: recommendations from the International Porphyria NetworkYonatan Edel, Penelope E Stein, Hassan Kawtharany, et al.
The Lancet. Haematology|May 18, 2026
Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trialAnthony Stein, Yan Wang, Monzr M Al Malki, et al.
Pageof 73